2021AJN American Journal of NursingRequires access

Labeling Changes for Vinca Alkaloid Chemotherapies

Diane S. Aschenbrenner

Open publisher page 0 citations

Abstract

The labeling for vinca alkaloid chemotherapy drugs is being revised to remove instructions for their administration with use of a syringe. This revision is in response to inadvertent intrathecal administration of vinca alkaloids, which is normally fatal.

About this research paper

What this paper is about

The labeling for vinca alkaloid chemotherapy drugs is being revised to remove instructions for their administration with use of a syringe. This revision is in response to inadvertent intrathecal administration of vinca alkaloids, which is normally fatal.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The labeling for vinca alkaloid chemotherapy drugs is being revised to remove instructions for their administration with use of a syringe. This revision is in response to inadvertent intrathecal administration of vinca alkaloids, which is normally fatal.

Key concepts: Vinca, Vinca alkaloid, Alkaloid, Pharmacology, Medicine, Chemotherapy, Chemistry, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Labeling Changes for Vinca Alkaloid Chemotherapies — Research Paper | ScholarLens